US 7,588,898 B2Granted

Biomarker for gestational trophoblastic disease

AssigneeAbnova (Taiwan) Corporation

InventorWilber Huang

Life of this patent

Estimating the term…

Abstract

A relatively specific trophoblastic-associated biomarker, HSD3B1, is disclosed. A method for screening gestational trophoblastic disease using HSD3B1 is also disclosed.

Claims7

Dependent claims

A method for screening gestational trophoblastic disease, comprising:

detecting the presence or level of Hydroxy-δ-5-steroid dehydrogenase, 3β- and steroid δ-isomerase 1 (HSD3B1)in a biological sample of a subject and correlating said detection to gestational trophoblastic disease.

Dependencies are inferred from the claim text.

Facts

Application: 11/804,288Filed 17 May 2007 · us provisional application
Priority: 31 Aug 2006
Published: US 2008/0138810 A112 Jun 2008
Granted: 15 Sep 2009
Term ends: Not estimatedThe source records don’t support an estimate.

Classification9 codes

G01N 33/5755
For cancer: of the uterine cervix, uterine corpus or endometrium
C12N 9/90
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes: isomerases
C12Y 503/03001
Transposing C=C bonds: steroid DELTA-isomerase
G01N 33/573
Immunoassay; Biospecific binding assay; Materials therefor: for enzymes or isoenzymes

Family

Application60/841,667Us provisional application · filed 31 Aug 2006
US 2008/0138810 A1Pre-grant publication · published 12 Jun 2008
US 7,588,898 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results